RecruitingPhase 1 / Phase 2NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Sponsor: Cabaletta Bio
Minneapolis, MN · +20 more sites
2 recruiting lupus studies with a site in Minneapolis, MN.
Sponsor: Cabaletta Bio
Minneapolis, MN · +20 more sites
Sponsor: Fate Therapeutics
Minneapolis, MN · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.